The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular classification of neuroendocrine carcinoma of the bladder.
 
Shijia Li
No Relationships to Disclose
 
Margaret Han
No Relationships to Disclose
 
Christina Thai
Employment - Tempus
Stock and Other Ownership Interests - 10X Genomics; Abbvie; AstraZeneca; BioNano Genomics; Illumina; Johnson & Johnson/Janssen; Lilly; Medtronic; Pfizer
Travel, Accommodations, Expenses - Tempus
 
Kayla Layng
Employment - Tempus
Stock and Other Ownership Interests - Adaptive Biotechnologies; Tempus
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Tempus
 
Lorenzo Grego
Employment - Tempus AI; Tempus AI
Stock and Other Ownership Interests - Tempus AI
 
Unnati Jariwala
Employment - Magnit Global (Daiichi Sankyo contract assignment); Tempus AI
Stock and Other Ownership Interests - Tempus AI
 
Jonathan Chou
Consulting or Advisory Role - Bicycle Therapeutics; Exai Bio; Inversion Therapeutics
Research Funding - Amgen (Inst)
 
Vadim Koshkin
Consulting or Advisory Role - Astellas Pharma; Bicycle Therapeutics; Bristol Myers Squibb Foundation; Janssen; Loxo; Merck; MSD; Natera; Pfizer; Roche/Genentech; Tempus
Research Funding - Curium Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer/Astellas (Inst); Seagen (Inst); Taiho Oncology (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
Terence Friedlander
Honoraria - Abbvie; Astellas Pharma; EMD Serono; Merck
Consulting or Advisory Role - AADi; Astellas Pharma; Atkis; Bicycle Therapeutics; Bristol-Myers Squibb/Medarex; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer
Research Funding - Bicycle Therapeutics; Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bicycle Therapeutics; Merck
 
Claire Mulvey
No Relationships to Disclose
 
Emily Bergsland
Leadership - More Health (I)
Stock and Other Ownership Interests - exai bio (I); More Health (I)
Research Funding - Boehringer Ingelheim (Inst); Merck (Inst); RayzeBio (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
(OPTIONAL) Uncompensated Relationships - Lantheus Medical Imaging
 
Rahul Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; Curio Science; EcoR1 Capital; Exelixis; Flare Therapeutics; Guidepoint Inc; Harpoon therapeutics; Janssen; Merck; MJH Life Sciences; Novartis; PCCTC; Pfizer; Research to Practice; Slingshot Insights; Tersera; Washington Research Foundation
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Eric Small
No Relationships to Disclose
 
Xiaolin Zhu
Employment - Pfizer (I)